Gene Therapy Firm Freeline Successfully Tops Up Series C

CEO Says $120m Financing Will Advance Key Clinical Programs

DNA
Freeline is developing curative gene therapies for chronic systemic disease. • Source: Shutterstock

More from Business

More from Scrip